© Copyright 2025 American Medical Association. All rights reserved.
Endoscopic retrograde cholangiopancreatography (ERCP) is a specialized procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions affecting the bile ducts and pancreatic duct. This procedure is particularly indicated when there are tumors, polyps, or other lesions that cannot be removed using standard techniques such as hot biopsy forceps, bipolar cautery, or snare techniques. During ERCP, a flexible endoscope is inserted through the esophagus, traversing the stomach, and advancing into the duodenum until it reaches the Ampulla of Vater, where the pancreatic duct and common bile duct converge. At this juncture, a smaller catheter is introduced through the endoscope to cannulate the Ampulla of Vater, allowing for the injection of contrast dye into the ducts. This contrast dye facilitates the visualization of the common bile duct, biliary tract, gallbladder, and pancreas through x-ray imaging, which is captured immediately after the dye is injected. Following this, the catheter is maneuvered over a guidewire into the relevant ducts, enabling a thorough examination for any tumors, polyps, or lesions. If such lesions are identified, an ablation device is utilized to target and treat the lesions, employing methods other than those previously mentioned, thereby allowing for the removal of one or more lesions effectively.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure of endoscopic retrograde cholangiopancreatography (ERCP) with ablation is indicated for the following conditions:
The procedure of ERCP with ablation involves several critical steps to ensure effective diagnosis and treatment:
After the completion of the ERCP with ablation, patients are typically monitored for any immediate complications. Post-procedure care may include observation for signs of bleeding, infection, or pancreatitis. Patients may experience some discomfort or mild sedation effects, and recovery time can vary. It is essential for healthcare providers to provide instructions regarding dietary restrictions and activity levels following the procedure, as well as to schedule any necessary follow-up appointments to assess the outcomes of the ablation and overall health status.
| Short Descr | ENDO CHOLANGIOPANCREATOGRAPH | Medium Descr | ERCP W/ABLTJ LES X RMVL FORCEPS/CAUT/SNARE | Long Descr | Endoscopic retrograde cholangiopancreatography (ERCP); with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | Status Code | Active Code | Global Days | 000 - Endoscopic or Minor Procedure | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 3 - Special rules for multiple endoscopic procedures apply... | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Endoscopic Base Code | 43260 Endoscopic retrograde cholangiopancreatography (ERCP); diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure) | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Multiple Reduction Applies | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 82 - Endoscopic retrograde cannulation of pancreas (ERCP) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2014-01-01 | Deleted | Code deleted, see 43278 |
| 2002-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.